136-150 of 981
RNAi Therapeutics in ATTR-CM: Clinical Evidence and Potential Impacts
On the Frontlines of ATTR-CMRNAi Therapeutics in ATTR-CM: Clinical Evidence and Potential Impacts
Shelina Ramnarine, PhD
Chadi Alraies, MD, MPH, FACC
Can AI Transform How We Diagnose ATTR-CM?
On the Frontlines of ATTR-CMCan AI Transform How We Diagnose ATTR-CM?
Ryan Quigley
Frederick Ruberg, MD
ATTRibute-CM Findings on Acoramidis and Cumulative CV Events
On the Frontlines of ATTR-CMATTRibute-CM Findings on Acoramidis and Cumulative CV Events
Ryan Quigley
Ahmad Masri, MD, MS
Redefining ATTR Treatment: Key Mechanisms and Emerging Data
Heart MattersRedefining ATTR Treatment: Key Mechanisms and Emerging Data
Ahmad Masri, MD, MS
When Alopecia Areata Signals More than Hair Loss
DermConsultWhen Alopecia Areata Signals More than Hair Loss
ATTRibute-CM Trial Updates: Long-Term Outcomes With Acoramidis
On the Frontlines of ATTR-CMATTRibute-CM Trial Updates: Long-Term Outcomes With Acoramidis
Ryan Quigley
Kevin Alexander, MD
- advertisement
Advances in ATTR-CM: Evolving Diagnostics and Therapeutics
Heart MattersAdvances in ATTR-CM: Evolving Diagnostics and Therapeutics
Kevin Alexander
"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
The Convergence"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
Brian P. McDonough, MD, FAAFP
Clement Papadacci, PhD
Patient Voices in ATTR-CM: Driving Change in Diagnosis, Referral, and Support
On the Frontlines of ATTR-CMPatient Voices in ATTR-CM: Driving Change in Diagnosis, Referral, and Support
Ryan Quigley
Quan Bui, MD
Treating ATTR-CM Early: A Shift From Reactive to Strategic Care
Heart MattersTreating ATTR-CM Early: A Shift From Reactive to Strategic Care
Quan Bui, MD
Recognizing Methamphetamine-Associated PAH: Strategies for Complex Care
Deep Breaths: Updates from CHESTRecognizing Methamphetamine-Associated PAH: Strategies for Complex Care
Rodolfo A. Estrada MD, FCCP
Steven M. Hollenberg, MD
Dana Kay, DO
Advancing Diagnosis of Transthyretin Cardiac Amyloidosis in Underserved Populations
Heart MattersAdvancing Diagnosis of Transthyretin Cardiac Amyloidosis in Underserved Populations
- advertisement
Exploring Tafamidis Survival Data in Elderly Patients with ATTR-CM
AudioAbstractsExploring Tafamidis Survival Data in Elderly Patients with ATTR-CM
Hallie Blevins, PhD
Understanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
Heart MattersUnderstanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
ATTR-CM Trials Revisited: A Broader View of Treatment Benefit
Heart MattersATTR-CM Trials Revisited: A Broader View of Treatment Benefit